(+)-pilocarpine increases expression ISO RGD:3959 6480464 Pilocarpine results in increased expression of VDR mRNA CTD PMID:18534255 (R)-noradrenaline increases abundance ISO RGD:619561 6480464 VDR protein results in increased abundance of Norepinephrine CTD PMID:27450565 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VDR mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of VDR mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:619561 6480464 Dinitrochlorobenzene results in increased expression of VDR mRNA CTD PMID:17374397 17alpha-ethynylestradiol multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein], VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 17alpha-ethynylestradiol increases expression ISO RGD:3959 6480464 Ethinyl Estradiol results in increased expression of VDR mRNA, Ethinyl Estradiol results in increased expression of VDR protein CTD PMID:20186393 17beta-estradiol multiple interactions ISO RGD:619561 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of VDR mRNA] more ... CTD PMID:15930183 more ... 17beta-estradiol decreases expression ISO RGD:619561 6480464 Estradiol results in decreased expression of VDR mRNA CTD PMID:31646340 17beta-estradiol increases expression ISO RGD:619561 6480464 Estradiol results in increased expression of VDR mRNA, Estradiol results in increased expression of VDR protein CTD PMID:15930183 more ... 17beta-estradiol multiple interactions ISO RGD:3959 6480464 Tamoxifen inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:1315250 17beta-estradiol increases expression ISO RGD:3959 6480464 Estradiol results in increased expression of VDR protein CTD PMID:1315250 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of VDR mRNA CTD PMID:15667827 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:3959 6480464 Tetrachlorodibenzodioxin affects the expression of VDR mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:619561 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of VDR mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of VDR mRNA CTD PMID:24035824 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:619561 6480464 Tetrachlorodibenzodioxin results in increased expression of VDR mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VDR mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to VDR promoter] CTD PMID:19654925 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:619561 6480464 2 more ... CTD PMID:26705709 24,25-Dihydroxyvitamin D increases activity EXP 6480464 24, 25-Dihydroxyvitamin D 3 results in increased activity of VDR protein CTD PMID:17997857 24,25-Dihydroxyvitamin D increases activity ISO RGD:619561 6480464 24, 25-Dihydroxyvitamin D 3 results in increased activity of VDR protein CTD PMID:17997857 3,7-dihydropurine-6-thione affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Mercaptopurine CTD PMID:15713801 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [1, 25-dihydroxyvitamin D results in increased activity of VDR protein] CTD PMID:18829283 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:3959 6480464 bisindolylmaleimide I inhibits the reaction [Calcitriol results in increased expression of VDR mRNA] more ... CTD PMID:20006981 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:619561 6480464 [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of VDR protein CTD PMID:33836827 3-methoxytyramine increases abundance ISO RGD:619561 6480464 VDR protein results in increased abundance of 3-methoxytyramine CTD PMID:27450565 3-methoxytyramine multiple interactions ISO RGD:619561 6480464 Calcitriol promotes the reaction [VDR protein results in increased abundance of 3-methoxytyramine] CTD PMID:27450565 3-oxo-5beta-cholanic acid increases activity ISO RGD:619561 6480464 3-oxocholan-24-oic acid results in increased activity of VDR protein CTD PMID:15708356 3-phenoxybenzoic acid affects binding ISO RGD:619561 6480464 3-phenoxybenzoic acid binds to VDR protein CTD PMID:32278787 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of VDR mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:619561 6480464 Fenretinide results in increased expression of VDR CTD PMID:17024972 4-hydroxyphenyl retinamide multiple interactions ISO RGD:619561 6480464 Cholecalciferol promotes the reaction [Fenretinide results in increased expression of VDR] CTD PMID:17024972 5-aza-2'-deoxycytidine multiple interactions ISO RGD:619561 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of VDR mRNA, [Decitabine co-treated with trichostatin A] results in increased expression of VDR protein CTD PMID:17891453 8-Br-cAMP increases expression ISO RGD:619561 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VDR mRNA CTD PMID:22079614 9-cis-retinoic acid multiple interactions ISO RGD:619561 6480464 [Alitretinoin co-treated with Calcitriol] results in increased stability of [RXRA protein binds to VDR protein], Alitretinoin promotes the reaction [VDR protein binds to BGLAP gene] CTD PMID:12898515 , PMID:16204233 9-cis-retinoic acid increases degradation ISO RGD:619561 6480464 Alitretinoin results in increased degradation of VDR protein CTD PMID:12898515 9-cis-retinoic acid affects activity ISO RGD:619561 6480464 Alitretinoin affects the activity of VDR protein CTD PMID:16936639 acetylsalicylic acid affects response to substance ISO RGD:619561 6480464 VDR polymorphism affects the susceptibility to Aspirin CTD PMID:15066917 afimoxifene decreases expression ISO RGD:619561 6480464 afimoxifene results in decreased expression of VDR protein CTD PMID:8593782 aflatoxin B1 increases expression ISO RGD:619561 6480464 Aflatoxin B1 results in increased expression of VDR mRNA CTD PMID:22100608 , PMID:32234424 aflatoxin B1 multiple interactions ISO RGD:619561 6480464 Aflatoxin B1 inhibits the reaction [Cholecalciferol affects the localization of VDR protein] more ... CTD PMID:36066700 aflatoxin B1 decreases expression ISO RGD:619561 6480464 Aflatoxin B1 results in decreased expression of VDR mRNA, Aflatoxin B1 results in decreased expression of VDR protein CTD PMID:25483621 , PMID:36066700 aflatoxin B1 affects response to substance ISO RGD:619561 6480464 VDR polymorphism affects the susceptibility to Aflatoxin B1 CTD PMID:25483621 aflatoxin B1 increases expression ISO RGD:3959 6480464 Aflatoxin B1 results in increased expression of VDR mRNA CTD PMID:23630614 , PMID:25378103 aldehydo-D-glucose multiple interactions ISO RGD:3959 6480464 [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA more ... CTD PMID:21788014 alendronic acid affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Alendronate CTD PMID:12608943 , PMID:15739035 alendronic acid multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to [Alendronate co-treated with Estrogens more ... CTD PMID:15739035 alfacalcidol increases activity EXP 6480464 alfacalcidol results in increased activity of VDR protein CTD PMID:17997857 , PMID:19581390 alfacalcidol increases activity ISO RGD:619561 6480464 alfacalcidol results in increased activity of VDR protein CTD PMID:17997857 alfacalcidol multiple interactions EXP 6480464 [alfacalcidol results in increased activity of VDR protein] which results in increased metabolism of Bile Acids and Salts CTD PMID:19581390 alfacalcidol affects binding ISO RGD:619561 6480464 alfacalcidol binds to [VDR protein binds to RXRA protein], alfacalcidol binds to VDR protein modified form CTD PMID:20947021 alfacalcidol multiple interactions ISO RGD:619561 6480464 alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to MED1 protein modified form], alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to NCOA1 protein modified form] CTD PMID:20947021 all-trans-retinoic acid multiple interactions ISO RGD:619561 6480464 [Cholecalciferol co-treated with Tretinoin] promotes the reaction [[VDR protein binds to RXRA protein] which binds to SLCO1A2 promoter] more ... CTD PMID:11504768 more ... all-trans-retinoic acid increases expression ISO RGD:619561 6480464 Tretinoin results in increased expression of VDR mRNA, Tretinoin results in increased expression of VDR protein CTD PMID:33167477 , PMID:7662588 alpha-linolenic acid increases expression ISO RGD:619561 6480464 alpha-Linolenic Acid results in increased expression of VDR mRNA CTD PMID:19667161 alpha-linolenic acid multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with alpha-Linolenic Acid] results in increased expression of VDR mRNA CTD PMID:19667161 alpha-naphthoflavone multiple interactions ISO RGD:619561 6480464 alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]] CTD PMID:19244278 ammonium chloride affects expression ISO RGD:3959 6480464 Ammonium Chloride affects the expression of VDR mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:619561 6480464 pyrazolanthrone inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:15930183 antirheumatic drug decreases expression ISO RGD:619561 6480464 Antirheumatic Agents results in decreased expression of VDR mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:619561 6480464 aristolochic acid I results in increased expression of VDR mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO RGD:619561 6480464 arsenite results in decreased expression of VDR mRNA, arsenite results in decreased expression of VDR protein CTD PMID:15037631 , PMID:31646340 bafilomycin A1 multiple interactions ISO RGD:619561 6480464 [bafilomycin A1 co-treated with Vitamin D] results in increased expression of VDR protein, [Silicon Dioxide co-treated with Vitamin D co-treated with bafilomycin A1] results in increased expression of VDR protein CTD PMID:30698894 benzene increases expression EXP 6480464 Benzene results in increased expression of VDR mRNA CTD PMID:12928149 benzo[a]pyrene multiple interactions EXP 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to VDR promoter] CTD PMID:19654925 benzo[a]pyrene decreases expression ISO RGD:3959 6480464 Benzo(a)pyrene results in decreased expression of VDR mRNA CTD PMID:34283317 benzo[a]pyrene increases expression ISO RGD:619561 6480464 Benzo(a)pyrene results in increased expression of VDR mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:619561 6480464 Benzo(a)pyrene results in decreased methylation of VDR 5' UTR, Benzo(a)pyrene results in decreased methylation of VDR promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of VDR mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with Benzo(a)pyrene] results in increased expression of VDR protein more ... CTD PMID:19244278 , PMID:22837390 bezafibrate multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with Bezafibrate] results in increased expression of VDR mRNA CTD PMID:19667161 biphenyl-2-ol affects binding ISO RGD:619561 6480464 2-phenylphenol binds to VDR protein CTD PMID:32278787 bisdemethoxycurcumin multiple interactions ISO RGD:619561 6480464 [bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of VDR mRNA CTD PMID:22029407 bisphenol A decreases expression ISO RGD:3959 6480464 bisphenol A results in decreased expression of VDR mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VDR mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:619561 6480464 [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of VDR protein CTD PMID:33836827 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Cholecalciferol] results in increased expression of VDR mRNA, [bisphenol A co-treated with Cholecalciferol] results in increased expression of VDR protein CTD PMID:32702508 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of VDR mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:3959 6480464 bisphenol A results in increased expression of VDR mRNA CTD PMID:30816183 bisphenol A increases methylation ISO RGD:3959 6480464 bisphenol A results in increased methylation of VDR gene CTD PMID:28505145 butanal increases expression ISO RGD:619561 6480464 butyraldehyde results in increased expression of VDR mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:619561 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VDR mRNA more ... CTD PMID:31646340 , PMID:35301059 cadmium atom decreases expression ISO RGD:619561 6480464 Cadmium results in decreased expression of VDR mRNA CTD PMID:31646340 cadmium dichloride multiple interactions ISO RGD:619561 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VDR mRNA, Cadmium Chloride promotes the reaction [VDR protein binds to NCOA2 protein] CTD PMID:21229763 , PMID:35301059 cadmium dichloride decreases expression ISO RGD:619561 6480464 Cadmium Chloride results in decreased expression of VDR mRNA CTD PMID:25596134 calcidiol increases activity EXP 6480464 Calcifediol results in increased activity of VDR protein CTD PMID:17997857 , PMID:21291553 calcidiol increases activity ISO RGD:619561 6480464 Calcifediol results in increased activity of VDR protein, Calcifediol results in increased activity of VDR protein mutant form CTD PMID:17997857 , PMID:21291553 calcidiol multiple interactions ISO RGD:619561 6480464 Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein] more ... CTD PMID:20079722 , PMID:24792400 calciol multiple interactions ISO RGD:619561 6480464 [Cholecalciferol binds to VDR protein] which results in increased expression of SLCO1A2 mRNA more ... CTD PMID:17024972 more ... calciol affects localization ISO RGD:619561 6480464 Cholecalciferol affects the localization of VDR protein CTD PMID:36066700 calciol multiple interactions ISO RGD:3959 6480464 Cholecalciferol inhibits the reaction [Dietary Fats results in decreased expression of VDR mRNA], Cholecalciferol inhibits the reaction [Gentamicins results in decreased expression of VDR protein] CTD PMID:29653100 , PMID:30458643 calciol multiple interactions EXP 6480464 [bisphenol A co-treated with Cholecalciferol] results in increased expression of VDR mRNA more ... CTD PMID:17008384 more ... calciol increases expression ISO RGD:619561 6480464 Cholecalciferol results in increased expression of VDR more ... CTD PMID:17024972 , PMID:36066700 calcipotriol multiple interactions ISO RGD:619561 6480464 calcipotriene affects the reaction [Calcitriol binds to VDR protein] more ... CTD PMID:30419252 , PMID:7530193 calcipotriol increases expression ISO RGD:619561 6480464 calcipotriene results in increased expression of VDR protein CTD PMID:30419252 calcipotriol affects response to substance ISO RGD:619561 6480464 VDR promoter SNP affects the susceptibility to calcipotriene CTD PMID:15864137 calcitriol multiple interactions ISO RGD:619561 6480464 1 more ... CTD PMID:10799658 more ... calcitriol increases expression ISO RGD:619561 6480464 Calcitriol results in increased expression of VDR mRNA, Calcitriol results in increased expression of VDR protein CTD PMID:11158396 more ... calcitriol increases phosphorylation ISO RGD:619561 6480464 Calcitriol results in increased phosphorylation of VDR protein CTD PMID:20371703 calcitriol affects binding ISO RGD:3959 6480464 Calcitriol analog binds to VDR protein, Calcitriol binds to VDR protein CTD PMID:17110116 more ... calcitriol increases activity EXP 6480464 Calcitriol results in increased activity of VDR protein CTD PMID:17997857 , PMID:21291553 calcitriol increases response to substance EXP 6480464 VDR results in increased susceptibility to Calcitriol CTD PMID:17035339 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of VDR mRNA, Calcitriol results in increased expression of VDR protein CTD PMID:16368784 more ... calcitriol decreases degradation EXP 6480464 Calcitriol results in decreased degradation of VDR protein CTD PMID:16467308 calcitriol multiple interactions EXP 6480464 Calcitriol binds to and results in increased activity of VDR protein mutant form more ... CTD PMID:15647825 more ... calcitriol affects localization EXP 6480464 Calcitriol affects the localization of VDR protein CTD PMID:15647825 calcitriol affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Calcitriol CTD PMID:15861036 calcitriol increases localization ISO RGD:619561 6480464 Calcitriol results in increased localization of VDR protein CTD PMID:16204233 calcitriol increases activity ISO RGD:619561 6480464 Calcitriol results in increased activity of VDR protein more ... CTD PMID:15992766 more ... calcitriol decreases expression ISO RGD:619561 6480464 Calcitriol results in decreased expression of VDR mRNA CTD PMID:16002434 calcitriol affects binding ISO RGD:619561 6480464 [Calcitriol binds to VDR protein] which binds to HOXA10 promoter more ... CTD PMID:10875257 more ... calcitriol increases expression ISO RGD:3959 6480464 Calcitriol results in increased expression of VDR more ... CTD PMID:15746989 more ... calcitriol multiple interactions ISO RGD:3959 6480464 1 more ... CTD PMID:20006981 more ... calcium atom affects metabolic processing ISO RGD:619561 6480464 VDR gene polymorphism affects the metabolism of Calcium CTD PMID:15883634 , PMID:16048257 calcium atom affects abundance EXP 6480464 VDR protein affects the abundance of Calcium CTD PMID:11500311 calcium atom affects expression ISO RGD:3959 6480464 Calcium affects the expression of VDR mRNA CTD PMID:15913539 calcium atom affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Calcium CTD PMID:15861036 calcium(0) affects metabolic processing ISO RGD:619561 6480464 VDR gene polymorphism affects the metabolism of Calcium CTD PMID:15883634 , PMID:16048257 calcium(0) affects abundance EXP 6480464 VDR protein affects the abundance of Calcium CTD PMID:11500311 calcium(0) affects expression ISO RGD:3959 6480464 Calcium affects the expression of VDR mRNA CTD PMID:15913539 calcium(0) affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Calcium CTD PMID:15861036 captopril multiple interactions EXP 6480464 Captopril promotes the reaction [LEPR protein affects the expression of VDR protein] CTD PMID:28130181 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of VDR mRNA CTD PMID:25554681 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of VDR mRNA CTD PMID:31978390 carnosic acid multiple interactions ISO RGD:619561 6480464 Calcitriol promotes the reaction [salvin results in increased expression of VDR protein] more ... CTD PMID:11504768 carnosic acid increases expression ISO RGD:619561 6480464 salvin results in increased expression of VDR protein CTD PMID:11504768 cefalotin multiple interactions EXP 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA CTD PMID:24657338 CGP 52608 multiple interactions ISO RGD:619561 6480464 CGP 52608 promotes the reaction [RORA protein binds to VDR gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO RGD:3959 6480464 bisindolylmaleimide I inhibits the reaction [Chenodeoxycholic Acid results in increased expression of VDR mRNA], Chenodeoxycholic Acid promotes the reaction [Calcitriol results in increased expression of VDR mRNA] CTD PMID:20006981 chenodeoxycholic acid increases expression ISO RGD:3959 6480464 Chenodeoxycholic Acid results in increased expression of VDR mRNA CTD PMID:20006981 chenodeoxycholic acid increases expression ISO RGD:619561 6480464 Chenodeoxycholic Acid results in increased expression of VDR mRNA CTD PMID:20006981 CHIR 99021 decreases expression ISO RGD:3959 6480464 Chir 99021 results in decreased expression of VDR mRNA, Chir 99021 results in decreased expression of VDR protein CTD PMID:34283317 chloroacetaldehyde decreases expression ISO RGD:619561 6480464 chloroacetaldehyde results in decreased expression of VDR mRNA CTD PMID:25596134 cholanic acid multiple interactions ISO RGD:619561 6480464 cholanic acid binds to and results in increased activity of VDR protein, cholanic acid binds to and results in increased activity of VDR protein mutant form CTD PMID:21291553 cholanic acid multiple interactions EXP 6480464 cholanic acid binds to and results in increased activity of VDR protein, cholanic acid binds to and results in increased activity of VDR protein mutant form CTD PMID:21291553 cholesterol affects binding ISO RGD:619561 6480464 Cholesterol metabolite binds to VDR protein CTD PMID:16051528 cholesterol affects abundance ISO RGD:619561 6480464 VDR gene SNP affects the abundance of Cholesterol CTD PMID:25498546 cholic acid increases localization ISO RGD:619561 6480464 Cholic Acid results in increased localization of VDR protein CTD PMID:20371703 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of VDR mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of VDR mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:619561 6480464 Cisplatin results in increased expression of VDR mRNA CTD PMID:27594783 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of VDR mRNA CTD PMID:35403300 copper(II) sulfate decreases expression ISO RGD:619561 6480464 Copper Sulfate results in decreased expression of VDR mRNA CTD PMID:19549813 curcumin multiple interactions ISO RGD:619561 6480464 [Curcumin binds to and results in increased activity of VDR protein] which results in increased expression of CDKN1A mRNA more ... CTD PMID:20153625 cyclophosphamide increases expression ISO RGD:3959 6480464 Cyclophosphamide results in increased expression of VDR mRNA CTD PMID:27281708 cyclosporin A decreases expression ISO RGD:619561 6480464 Cyclosporine results in decreased expression of VDR mRNA CTD PMID:25596134 cytarabine affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Cytarabine CTD PMID:15713801 D-glucose multiple interactions ISO RGD:3959 6480464 [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA more ... CTD PMID:21788014 daunorubicin decreases activity ISO RGD:619561 6480464 Daunorubicin results in decreased activity of VDR protein CTD PMID:25257666 daunorubicin affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Daunorubicin CTD PMID:15713801 desferrioxamine B increases expression ISO RGD:619561 6480464 Deferoxamine results in increased expression of VDR mRNA CTD PMID:20368581 dexamethasone multiple interactions EXP 6480464 Dexamethasone promotes the reaction [1, 25-dihydroxyvitamin D results in increased expression of VDR protein] CTD PMID:11751517 dexamethasone multiple interactions ISO RGD:619561 6480464 [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of VDR protein CTD PMID:33836827 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of VDR mRNA CTD PMID:10694374 , PMID:22733784 dexamethasone decreases expression ISO RGD:3959 6480464 Dexamethasone results in decreased expression of VDR mRNA CTD PMID:20006981 dexamethasone increases expression ISO RGD:619561 6480464 Dexamethasone results in increased expression of VDR mRNA CTD PMID:20006981 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VDR mRNA CTD PMID:29950665 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of VDR mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:619561 6480464 dicrotophos results in increased expression of VDR mRNA CTD PMID:28302478 dimethylarsinic acid decreases expression ISO RGD:3959 6480464 Cacodylic Acid results in decreased expression of VDR mRNA CTD PMID:16122865 dioxygen decreases expression ISO RGD:619561 6480464 Oxygen deficiency results in decreased expression of VDR mRNA CTD PMID:25596134 disodium selenite decreases expression ISO RGD:619561 6480464 Sodium Selenite results in decreased expression of VDR mRNA CTD PMID:16928829 dopamine increases abundance ISO RGD:619561 6480464 VDR protein results in increased abundance of Dopamine CTD PMID:27450565 dorsomorphin multiple interactions ISO RGD:619561 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VDR mRNA CTD PMID:27188386 doxorubicin decreases activity ISO RGD:619561 6480464 Doxorubicin results in decreased activity of VDR protein CTD PMID:25257666 doxorubicin decreases expression ISO RGD:619561 6480464 Doxorubicin results in decreased expression of VDR mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:619561 6480464 Doxorubicin results in increased expression of VDR mRNA CTD PMID:17716971 endosulfan multiple interactions ISO RGD:619561 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of VDR mRNA CTD PMID:26159488 entinostat increases expression ISO RGD:619561 6480464 entinostat results in increased expression of VDR mRNA CTD PMID:27188386 estriol increases expression ISO RGD:619561 6480464 Estriol results in increased expression of VDR mRNA CTD PMID:14992164 , PMID:15775415 etoposide multiple interactions ISO RGD:619561 6480464 [[Etoposide results in increased expression of TP73 protein] which results in increased expression of VDR protein] which results in increased susceptibility to Calcitriol, TP73 protein affects the reaction [Etoposide results in increased expression of VDR mRNA] CTD PMID:17716971 etoposide affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Etoposide, VDR intron polymorphism affects the susceptibility to Etoposide CTD PMID:12969965 , PMID:15713801 etoposide increases expression ISO RGD:619561 6480464 Etoposide results in increased expression of VDR mRNA CTD PMID:17716971 eugenol increases expression ISO RGD:619561 6480464 Eugenol results in increased expression of VDR mRNA CTD PMID:17374397 Falecalcitriol multiple interactions ISO RGD:619561 6480464 26 more ... CTD PMID:16059639 Falecalcitriol increases activity ISO RGD:619561 6480464 26 more ... CTD PMID:16059639 fenvalerate increases expression ISO RGD:3959 6480464 fenvalerate results in increased expression of VDR mRNA CTD PMID:30307764 flucythrinate affects binding ISO RGD:619561 6480464 flucythrinate binds to VDR protein CTD PMID:32278787 folic acid increases expression EXP 6480464 Folic Acid results in increased expression of VDR mRNA CTD PMID:30405444 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VDR mRNA CTD PMID:22206623 fulvestrant multiple interactions ISO RGD:619561 6480464 Cadmium inhibits the reaction [Fulvestrant results in decreased expression of VDR mRNA] more ... CTD PMID:17088408 , PMID:31646340 fulvestrant decreases expression ISO RGD:619561 6480464 Fulvestrant results in decreased expression of VDR mRNA, Fulvestrant results in decreased expression of VDR protein CTD PMID:15930183 , PMID:31646340 gamma-tocopherol increases expression ISO RGD:619561 6480464 Tocopherols results in increased expression of VDR mRNA CTD PMID:12032296 genistein multiple interactions ISO RGD:619561 6480464 fulvestrant inhibits the reaction [Genistein results in increased expression of VDR protein] more ... CTD PMID:12710998 more ... genistein increases expression ISO RGD:619561 6480464 Genistein results in increased expression of VDR mRNA, Genistein results in increased expression of VDR protein CTD PMID:12710998 , PMID:17088408 gentamycin decreases expression ISO RGD:3959 6480464 Gentamicins results in decreased expression of VDR protein CTD PMID:30458643 gentamycin multiple interactions ISO RGD:3959 6480464 Cholecalciferol inhibits the reaction [Gentamicins results in decreased expression of VDR protein] CTD PMID:30458643 glucose multiple interactions ISO RGD:3959 6480464 [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA more ... CTD PMID:21788014 glycitein multiple interactions ISO RGD:619561 6480464 fulvestrant inhibits the reaction [glycitein results in increased expression of VDR protein] more ... CTD PMID:17088408 glycitein increases expression ISO RGD:619561 6480464 glycitein results in increased expression of VDR mRNA, glycitein results in increased expression of VDR protein CTD PMID:17088408 Goe 6976 multiple interactions ISO RGD:619561 6480464 Go 6976 inhibits the reaction [isopentenyl pyrophosphate results in increased expression of VDR protein] CTD PMID:15879110 Goe 6976 multiple interactions EXP 6480464 Go 6976 inhibits the reaction [1, 25-dihydroxyvitamin D results in increased activity of VDR protein] CTD PMID:18829283 guggulsterone multiple interactions EXP 6480464 pregna-4 more ... CTD PMID:17959142 GW 501516 increases expression ISO RGD:619561 6480464 GW 501516 results in increased expression of VDR mRNA CTD PMID:19667161 GW 501516 multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with GW 501516] results in increased expression of VDR mRNA CTD PMID:19667161 hexachlorobenzene multiple interactions EXP 6480464 [Hexachlorobenzene co-treated with Diethylnitrosamine] results in decreased expression of VDR protein, Cholecalciferol inhibits the reaction [[Hexachlorobenzene co-treated with Diethylnitrosamine] results in increased expression of VDR protein] CTD PMID:28634113 homovanillic acid multiple interactions ISO RGD:619561 6480464 Calcitriol promotes the reaction [VDR protein results in increased abundance of Homovanillic Acid] CTD PMID:27450565 homovanillic acid increases abundance ISO RGD:619561 6480464 VDR protein results in increased abundance of Homovanillic Acid CTD PMID:27450565 idarubicin decreases activity ISO RGD:619561 6480464 Idarubicin results in decreased activity of VDR protein CTD PMID:25257666 iron atom increases expression ISO RGD:619561 6480464 Iron deficiency results in increased expression of VDR mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:619561 6480464 Iron deficiency results in increased expression of VDR mRNA CTD PMID:20368581 isopentenyl diphosphate multiple interactions ISO RGD:619561 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [isopentenyl pyrophosphate results in increased expression of VDR protein] more ... CTD PMID:15879110 isopentenyl diphosphate increases expression ISO RGD:619561 6480464 isopentenyl pyrophosphate results in increased expression of VDR protein CTD PMID:15879110 kaempferol increases activity ISO RGD:619561 6480464 kaempferol results in increased activity of VDR protein CTD PMID:26366751 ketoconazole multiple interactions ISO RGD:619561 6480464 Ketoconazole inhibits the reaction [Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]], Ketoconazole inhibits the reaction [Vitamin D analog results in increased activity of VDR protein] CTD PMID:16280049 , PMID:24792400 lacidipine increases activity ISO RGD:619561 6480464 lacidipine results in increased activity of VDR protein CTD PMID:25257666 lactacystin decreases degradation ISO RGD:619561 6480464 lactacystin results in decreased degradation of VDR protein CTD PMID:24792400 lamivudine multiple interactions EXP 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of VDR mRNA CTD PMID:11741158 lead diacetate multiple interactions ISO RGD:619561 6480464 lead acetate promotes the reaction [VDR protein binds to NCOA2 protein] CTD PMID:21229763 lead(0) affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Lead more ... CTD PMID:11049814 more ... lead(0) affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of Lead CTD PMID:19515364 more ... lead(0) increases response to substance ISO RGD:619561 6480464 VDR gene polymorphism results in increased susceptibility to Lead, VDR gene SNP results in increased susceptibility to Lead CTD PMID:22101007 , PMID:32340109 lead(0) multiple interactions ISO RGD:619561 6480464 [VDR gene polymorphism co-treated with ALAD gene polymorphism] affects the abundance of Lead CTD PMID:19515364 lead(2+) affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of Lead CTD PMID:19515364 more ... lead(2+) multiple interactions ISO RGD:619561 6480464 [VDR gene polymorphism co-treated with ALAD gene polymorphism] affects the abundance of Lead CTD PMID:19515364 lead(2+) affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Lead more ... CTD PMID:11049814 more ... lead(2+) increases response to substance ISO RGD:619561 6480464 VDR gene polymorphism results in increased susceptibility to Lead, VDR gene SNP results in increased susceptibility to Lead CTD PMID:22101007 , PMID:32340109 levonorgestrel multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein], VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 lipopolysaccharide multiple interactions ISO RGD:3959 6480464 [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA more ... CTD PMID:21788014 lipopolysaccharide multiple interactions ISO RGD:619561 6480464 Lipopolysaccharides inhibits the reaction [Calcitriol results in increased expression of VDR protein], Lipopolysaccharides results in decreased expression of and results in decreased activity of VDR protein CTD PMID:15876428 lithocholic acid multiple interactions EXP 6480464 Lithocholic Acid binds to and results in increased activity of VDR protein more ... CTD PMID:15824121 more ... lithocholic acid affects binding ISO RGD:619561 6480464 Lithocholic Acid analog binds to VDR protein more ... CTD PMID:14525957 more ... lithocholic acid increases phosphorylation ISO RGD:619561 6480464 Lithocholic Acid results in increased phosphorylation of VDR protein CTD PMID:20371703 lithocholic acid affects binding ISO RGD:3959 6480464 Lithocholic Acid binds to VDR protein CTD PMID:19562681 , PMID:23723390 lithocholic acid increases expression ISO RGD:619561 6480464 Lithocholic Acid results in increased expression of VDR mRNA, Lithocholic Acid results in increased expression of VDR protein CTD PMID:20006981 , PMID:31472180 lithocholic acid decreases expression ISO RGD:3959 6480464 Lithocholic Acid results in decreased expression of VDR mRNA CTD PMID:20006981 lithocholic acid multiple interactions ISO RGD:3959 6480464 [Lithocholic Acid binds to and results in increased activity of VDR protein] which results in increased expression of CYP24A1 mRNA more ... CTD PMID:19562681 , PMID:21311750 lithocholic acid increases activity ISO RGD:619561 6480464 Lithocholic Acid metabolite results in increased activity of VDR protein, Lithocholic Acid results in increased activity of VDR protein CTD PMID:21543282 more ... lithocholic acid multiple interactions ISO RGD:619561 6480464 [Lithocholic Acid analog binds to and results in increased activity of VDR protein] which results in increased expression of CYP24A1 mRNA more ... CTD PMID:15489543 more ... LY294002 multiple interactions ISO RGD:619561 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [HRAS protein inhibits the reaction [1, 25-dihydroxyvitamin D results in increased activity of VDR protein]] CTD PMID:18829283 manidipine increases activity ISO RGD:619561 6480464 manidipine results in increased activity of VDR protein CTD PMID:25257666 Maxacalcitol multiple interactions ISO RGD:619561 6480464 maxacalcitol affects the reaction [Calcitriol binds to VDR protein] CTD PMID:7530193 medroxyprogesterone acetate multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to [Alendronate co-treated with Estrogens more ... CTD PMID:15739035 mercaptopurine affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Mercaptopurine CTD PMID:15713801 mercury atom affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of Mercury CTD PMID:25728017 mercury(0) affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of Mercury CTD PMID:25728017 methotrexate affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Methotrexate CTD PMID:15713801 methotrexate increases expression ISO RGD:619561 6480464 Methotrexate results in increased expression of VDR mRNA CTD PMID:21678067 methoxsalen multiple interactions ISO RGD:619561 6480464 Methoxsalen affects the reaction [VDR protein affects the expression of CYP7A1 protein], VDR protein affects the reaction [Methoxsalen results in increased expression of NR0B2 protein] CTD PMID:30419252 methoxsalen increases expression ISO RGD:619561 6480464 Methoxsalen results in increased expression of VDR protein CTD PMID:30419252 methyl beta-cyclodextrin multiple interactions ISO RGD:619561 6480464 methyl-beta-cyclodextrin inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:15930183 methylseleninic acid affects expression ISO RGD:619561 6480464 methylselenic acid affects the expression of VDR mRNA CTD PMID:16928829 N-nitrosodiethylamine multiple interactions EXP 6480464 [Hexachlorobenzene co-treated with Diethylnitrosamine] results in decreased expression of VDR protein, Cholecalciferol inhibits the reaction [[Hexachlorobenzene co-treated with Diethylnitrosamine] results in increased expression of VDR protein] CTD PMID:28634113 neomycin multiple interactions EXP 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA CTD PMID:24657338 nickel atom multiple interactions ISO RGD:619561 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of VDR mRNA] CTD PMID:14575637 nickel atom affects expression ISO RGD:619561 6480464 Nickel affects the expression of VDR mRNA CTD PMID:14575637 nickel sulfate increases expression ISO RGD:619561 6480464 nickel sulfate results in increased expression of VDR mRNA CTD PMID:17374397 , PMID:22714537 O-methyleugenol increases expression ISO RGD:619561 6480464 methyleugenol results in increased expression of VDR mRNA CTD PMID:32234424 okadaic acid multiple interactions ISO RGD:619561 6480464 [1 more ... CTD PMID:16059639 paracetamol increases expression ISO RGD:619561 6480464 Acetaminophen results in increased expression of VDR mRNA CTD PMID:29067470 paraquat decreases expression ISO RGD:3959 6480464 Paraquat results in decreased expression of VDR mRNA CTD PMID:32680482 paricalcitol multiple interactions ISO RGD:619561 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of VDR protein more ... CTD PMID:16076355 , PMID:17715259 paricalcitol affects binding ISO RGD:619561 6480464 paricalcitol binds to VDR protein CTD PMID:15898824 pentanal increases expression ISO RGD:619561 6480464 pentanal results in increased expression of VDR mRNA CTD PMID:26079696 perfluorooctanoic acid multiple interactions ISO RGD:619561 6480464 perfluorooctanoic acid inhibits the reaction [Calcitriol binds to VDR protein] CTD PMID:33033332 phenobarbital decreases expression ISO RGD:3959 6480464 Phenobarbital results in decreased expression of VDR mRNA CTD PMID:19162173 phenothrin affects binding ISO RGD:619561 6480464 phenothrin binds to VDR protein CTD PMID:32278787 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:619561 6480464 Tetradecanoylphorbol Acetate promotes the reaction [salvin results in increased expression of VDR protein] CTD PMID:11504768 phorbol 13-acetate 12-myristate increases expression ISO RGD:3959 6480464 Tetradecanoylphorbol Acetate results in increased expression of VDR mRNA CTD PMID:20006981 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:3959 6480464 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VDR mRNA] CTD PMID:20006981 phorbol 13-acetate 12-myristate increases expression ISO RGD:619561 6480464 Tetradecanoylphorbol Acetate results in increased expression of VDR mRNA, Tetradecanoylphorbol Acetate results in increased expression of VDR protein CTD PMID:20006981 , PMID:9348195 phosphorus atom affects expression ISO RGD:619561 6480464 Phosphorus affects the expression of VDR protein CTD PMID:17715259 phosphorus atom multiple interactions ISO RGD:619561 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of VDR protein, [Phosphorus co-treated with paricalcitol] results in increased localization of VDR protein CTD PMID:17715259 phosphorus(.) affects expression ISO RGD:619561 6480464 Phosphorus affects the expression of VDR protein CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:619561 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of VDR protein, [Phosphorus co-treated with paricalcitol] results in increased localization of VDR protein CTD PMID:17715259 pirinixic acid multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with pirinixic acid] results in increased expression of VDR mRNA CTD PMID:19667161 pirinixic acid increases expression ISO RGD:619561 6480464 pirinixic acid results in increased expression of VDR mRNA CTD PMID:19667161 potassium chromate decreases expression ISO RGD:619561 6480464 potassium chromate(VI) results in decreased expression of VDR mRNA CTD PMID:22714537 prednisone increases expression ISO RGD:619561 6480464 Prednisone results in increased expression of VDR protein CTD PMID:7662588 prednisone affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Prednisone CTD PMID:15713801 promegestone increases expression ISO RGD:619561 6480464 Promegestone results in increased expression of VDR protein CTD PMID:7662588 propanal increases expression ISO RGD:619561 6480464 propionaldehyde results in increased expression of VDR mRNA CTD PMID:26079696 purine-6-thiol affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Mercaptopurine CTD PMID:15713801 pyridaben increases activity ISO RGD:619561 6480464 pyridaben results in increased activity of VDR protein CTD PMID:20143881 quercetin increases activity ISO RGD:619561 6480464 Quercetin results in increased activity of VDR protein CTD PMID:26366751 quercetin increases response to substance ISO RGD:619561 6480464 VDR results in increased susceptibility to Quercetin CTD PMID:26366751 quercetin multiple interactions ISO RGD:619561 6480464 VDR promotes the reaction [Quercetin results in increased expression of ABCB1 mRNA] more ... CTD PMID:26366751 raloxifene affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Raloxifene Hydrochloride CTD PMID:15739035 , PMID:16604479 raloxifene multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to [Alendronate co-treated with Raloxifene Hydrochloride] CTD PMID:15739035 resveratrol multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with resveratrol] results in increased expression of VDR mRNA more ... CTD PMID:12710998 more ... resveratrol increases expression ISO RGD:619561 6480464 resveratrol results in increased expression of VDR mRNA, resveratrol results in increased expression of VDR protein CTD PMID:12710998 , PMID:15280659 rotenone increases activity ISO RGD:619561 6480464 Rotenone results in increased activity of VDR protein CTD PMID:20143881 saracatinib multiple interactions ISO RGD:619561 6480464 saracatinib inhibits the reaction [Calcitriol results in increased phosphorylation of VDR protein], saracatinib inhibits the reaction [lithocholic acid acetate results in increased phosphorylation of VDR protein] CTD PMID:20371703 SB 431542 multiple interactions ISO RGD:619561 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VDR mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:619561 6480464 Silicon Dioxide analog results in increased expression of VDR mRNA CTD PMID:25895662 silicon dioxide multiple interactions ISO RGD:619561 6480464 [Silicon Dioxide co-treated with Vitamin D co-treated with bafilomycin A1] results in increased expression of VDR protein, [Silicon Dioxide co-treated with Vitamin D] results in increased expression of VDR protein CTD PMID:30698894 silicon dioxide multiple interactions EXP 6480464 [Silicon Dioxide co-treated with Vitamin D] results in increased expression of VDR protein CTD PMID:30698894 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of VDR mRNA CTD PMID:19262002 sodium arsenite increases expression ISO RGD:619561 6480464 sodium arsenite results in increased expression of VDR mRNA CTD PMID:22714537 , PMID:34032870 sodium atom multiple interactions EXP 6480464 VDR protein affects the reaction [FGF23 protein results in decreased transport of [Sodium co-treated with Phosphates]] CTD PMID:16076377 sotorasib multiple interactions ISO RGD:619561 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of VDR mRNA CTD PMID:36139627 staurosporine increases cleavage ISO RGD:619561 6480464 Staurosporine results in increased cleavage of VDR protein CTD PMID:18832097 streptozocin decreases expression ISO RGD:3959 6480464 Streptozocin results in decreased expression of VDR mRNA, Streptozocin results in decreased expression of VDR protein CTD PMID:29953732 streptozocin multiple interactions ISO RGD:3959 6480464 Calcitriol inhibits the reaction [Streptozocin results in decreased expression of VDR mRNA], Calcitriol inhibits the reaction [Streptozocin results in decreased expression of VDR protein] CTD PMID:29953732 sunitinib increases expression ISO RGD:619561 6480464 Sunitinib results in increased expression of VDR mRNA CTD PMID:31533062 superoxide decreases abundance EXP 6480464 VDR protein results in decreased abundance of Superoxides CTD PMID:25201890 suramin multiple interactions ISO RGD:619561 6480464 Suramin inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:15930183 tamoxifen multiple interactions ISO RGD:3959 6480464 Tamoxifen inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:1315250 tamoxifen multiple interactions ISO RGD:619561 6480464 Tamoxifen inhibits the reaction [Genistein results in increased expression of VDR mRNA], Tamoxifen inhibits the reaction [resveratrol results in increased expression of VDR mRNA] CTD PMID:12710998 terbufos affects response to substance ISO RGD:619561 6480464 VDR gene SNP affects the susceptibility to terbufos CTD PMID:23833127 tetrachloromethane decreases expression ISO RGD:3959 6480464 Carbon Tetrachloride results in decreased expression of VDR mRNA CTD PMID:31150632 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VDR mRNA CTD PMID:29950665 tocopherol increases expression ISO RGD:619561 6480464 Tocopherols results in increased expression of VDR mRNA CTD PMID:12032296 trametinib multiple interactions ISO RGD:619561 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of VDR mRNA CTD PMID:36139627 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of VDR mRNA CTD PMID:30027469 trichostatin A multiple interactions ISO RGD:619561 6480464 [decitabine co-treated with trichostatin A] results in increased expression of VDR mRNA more ... CTD PMID:14575637 more ... trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of VDR mRNA CTD PMID:19042947 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of VDR mRNA CTD PMID:19122273 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of VDR mRNA CTD PMID:19122273 uranium atom decreases expression ISO RGD:3959 6480464 Uranium results in decreased expression of VDR mRNA CTD PMID:17118558 valproic acid multiple interactions ISO RGD:619561 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:21115105 more ... valproic acid decreases methylation ISO RGD:619561 6480464 Valproic Acid results in decreased methylation of VDR gene CTD PMID:29501571 valproic acid increases expression ISO RGD:619561 6480464 Valproic Acid results in increased expression of VDR mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:619561 6480464 Valproic Acid affects the expression of VDR mRNA CTD PMID:25979313 vincristine affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Vincristine CTD PMID:15713801 vitamin D multiple interactions ISO RGD:619561 6480464 [bafilomycin A1 co-treated with Vitamin D] results in increased expression of VDR protein more ... CTD PMID:16280049 more ... vitamin D increases expression ISO RGD:619561 6480464 Vitamin D results in increased expression of VDR mRNA, Vitamin D results in increased expression of VDR protein CTD PMID:30698894 , PMID:33309619 vitamin D multiple interactions EXP 6480464 [Particulate Matter co-treated with Vitamin D] results in increased expression of VDR protein, [Silicon Dioxide co-treated with Vitamin D] results in increased expression of VDR protein CTD PMID:30698894 vitamin D increases expression EXP 6480464 Vitamin D results in increased expression of VDR protein CTD PMID:30698894 vitamin D increases expression ISO RGD:3959 6480464 Vitamin D deficiency results in increased expression of VDR protein CTD PMID:9525346 vitamin D increases activity ISO RGD:619561 6480464 Vitamin D analog results in increased activity of VDR protein CTD PMID:16280049 warfarin affects response to substance ISO RGD:619561 6480464 VDR gene SNP affects the susceptibility to Warfarin CTD PMID:28262345 , PMID:29298995 zidovudine multiple interactions EXP 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of VDR mRNA CTD PMID:11741158 zinc atom increases activity ISO RGD:619561 6480464 Zinc deficiency results in increased activity of VDR protein CTD PMID:18356318 zinc protoporphyrin affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of zinc protoporphyrin CTD PMID:25963508 zinc(0) increases activity ISO RGD:619561 6480464 Zinc deficiency results in increased activity of VDR protein CTD PMID:18356318